Kiratli Hayyam, Kiliç Meltem, Tarlan Berçin, Söylemezoglu Figen
1 Ocular Oncology Service, Department of Ophthalmology, Hacettepe University School of Medicine, Ankara - Turkey.
Eur J Ophthalmol. 2015 Jul-Aug;25(4):288-92. doi: 10.5301/ejo.5000555. Epub 2015 Jan 15.
Adult-onset asthma with periocular xanthogranuloma and adult-onset xanthogranuloma are 2 rare subtypes of non-Langerhans cell histiocytic disorder and much remains unknown regarding optimal treatment. The authors describe their experience in the management of these 2 disease subtypes.
This is a retrospective case series with histopathologically proven orbital xanthogranuloma over a period of 12 years. Clinical, imaging, and histopathologic features; associated systemic conditions; treatment modality; and outcome during follow-up of 6 adult patients who had adult-onset asthma with periocular xanthogranuloma and adult-onset xanthogranuloma were reviewed.
The age range was 29-75 years (median 56 years). The duration of symptoms and signs varied from 10 months to 9 years. All patients had bilateral and asymmetric involvement. Palpebral swelling with yellow discoloration and upper eyelid ptosis were the most common signs. Adult-onset asthma was present in 2 patients. Imaging studies demonstrated ill-defined infiltrative lesions involving the preseptal area, lacrimal glands, extraocular muscles, retrobulbar fat, and optic nerves. The median follow-up was 50 months. Complete regression of all clinical signs was obtained at 8 months, whereas imaging findings disappeared at 18 months with treatment. No recurrence was observed.
Treatment consisting of debulking as much affected soft tissue as possible followed by a 3-day course of intravenous pulse methylprednisolone administration and then by oral prednisone for at least 6 months may provide adequate regression of the granulomas without recurrence and satisfactory cosmesis in patients with adult orbital xanthogranuloma with and without asthma.
成人起病的哮喘合并眶周黄色瘤及成人起病的黄色瘤是2种罕见的非朗格汉斯细胞组织细胞增多症亚型,关于最佳治疗仍有很多未知之处。作者描述了他们在这2种疾病亚型管理方面的经验。
这是一项回顾性病例系列研究,纳入了12年间经组织病理学证实的眼眶黄色瘤患者。回顾了6例患有成人起病的哮喘合并眶周黄色瘤及成人起病的黄色瘤患者的临床、影像学和组织病理学特征;相关的全身状况;治疗方式;以及随访期间的结局。
年龄范围为29 - 75岁(中位年龄56岁)。症状和体征持续时间从10个月到9年不等。所有患者均为双侧不对称受累。睑肿胀伴黄色变色及上睑下垂是最常见的体征。2例患者存在成人起病的哮喘。影像学检查显示边界不清的浸润性病变累及眶隔前区、泪腺、眼外肌、球后脂肪和视神经。中位随访时间为50个月。治疗后8个月所有临床体征完全消退,而影像学表现于18个月时消失,未观察到复发。
对于患有或未患有哮喘的成人眼眶黄色瘤患者,治疗方法包括尽可能多地切除受累软组织,随后静脉注射脉冲甲基强的松龙3天疗程,然后口服强的松至少6个月,这可能使肉芽肿充分消退且无复发,并获得满意的美容效果。